Chemiluminescence Immunoassay Procalcitonin PCT Whole Blood Reagents

Chemiluminescence Immunoassay Procalcitonin PCT Whole Blood Reagents

Brand :Norman

Product origin :Nanjing

Delivery time :Two weeks after payment

Supply capacity :100,000 units/month

For Automated Chemiluminescence Immunoassay Analyzer (CLIA-NRM-411), currently there are 19 reagents are available:
1. Inflammation/Infection
PCT (peripheral blood, whole blood, serum)
2. Cardiovascular (all cardiac markers support whole blood sample type)
NT-proBNP, D-Dimer, hs-cTnI, CK-MB, MYO, H-FABP, Lp-PLA2
3. Thyroid
T4, FT4, T3, FT3, TSH, TG, Anti TG, Anti TPO, Anti TSHR, T-Uptake
4. Fertility markers will be available at the end of 2018.
E2, Free-Beta-HCG, FSH, GH, LH, PRL, PROG, TESTO, uE3, Beta-HCG, INHIBINA, AFP, and PAPP-A

Chemiluminescence Immunoassay Superior Procalcitonin (PCT) Reagents:


Prouduct show :

1543891395(1).png 


Intended Use

PCT Kit (Fluorescein Enhanced Chemiluminescence Immunoassay) is intended for in vitro quantitative determination of Procalcitonin (PCT) in human serum, plasma and whole blood, using chemiluminescence immunoassay (CLIA) analyzer NRM411.

PCT is a 116-amino acid peptide and has a molecular weight of approximately 12.7 kD. Under normal metabolic conditions, procalcitonin is expressed by neuroendocrine cells (including C cells of the thyroid gland, lung and pancreas), where it undergoes proteolysis to yield the hormone calcitonin, C-terminal peptide and N-terminal peptide. Only a small amount of PCT is contained in healthy people’s blood. PCT will be significantly increased after bacterial infection.

PCT is a specific marker of inflammatory disorder caused by bacterial infection and a significant indicator of SIRS and sepsis, especially severe sepsis and septic shock caused by bacterial infection. PCT plays an important role in identifying inflammatory disorder caused by infection and non-infection (such as autoimmune inflammation and acute rejection after transplantation). Meanwhile, PCT detection is of great significance in guiding rational use of antibiotics, evaluating therapeutic effect and shortening the time of antibiotics use.


Principle of the Procedure

The assay is a sandwich immunoassay for quantitative determination of PCT concentration based on chemiluminescence immunoassay technology. The magnetic microbeads are labelled with an anti-PCT monoclonal antibody via a FITC amplification system and another anti-PCT monoclonal antibody is labelled with acridinium ester.Sample, calibrator or control is mixed with Magnetic Microbeads Reagent and Antibody Reagent to form a sandwich complex. After incubation and automatic magnetic separation, trigger solutions are added to generate chemiluminescent reaction and the RLUs are measured by a photomultiplier. A proportional relationship presents between the concentration of PCT and the RLUs detected by the NRM411 system.



PCT :                                                                                                               

1. Registration No: Jiangsu food and drug administration 2014-2400660

2. Initiatedchemiluminescenceperipheralwholoe blood PCT testing,especially recommended for children's hospitals and pediatric outpatient /emergency test. High accuracy, recommended to purchase aftercomparison test with Roche.


Clinical significance:                                                                                       

PCT is a powerful auxiliary tool for infectious diseases diagnosis, stratification, therapy and
prognostic evaluations well as reasonable use of antibiotics. Doctors should raise attention
degree towards PCT test. Start diagnosis and treatment monitoring from patient suspected 
of infectious diseases enter hospital, lay the foundation for the subsequent treatment.

PCT Theclinic and emergency application expert consensus - Chinese Journal of Emergency Medicine (No. 9,Volume 21,September 2012)


Applicable department:                                                                                   

Pediatrics, ICU, emergency, respiratory, surgical, hospital ward, internal medicine, oncology, hematology.


Product advantage:                                                                                         

1. Advanced technology: initiate peripheral whole blood chemiluminescence PCT test.

2. High sensitivity: 0.02ng/ml.

3. High accuracy:99% correlation with Roche ELECSYS BRAHMS PCT.

4. Wide linear range: 0.02 ∽ 100ng/ml.

5. Good repeatability: CV≤5%.


Related products:

1536054247(1)_副本_副本.jpg


Company profile:                                                                                            

1. Nanjing Norman Biological Technology Co., Ltd is dedicated to R&D and manufacturing of automated chemiluminescence system. Founded in 2008, Norman biological has been upholding the idea that R&D shapes future ,and concentration determines success. Ever since the beginning,Norman has been focusing on developing and manufacturing  chemiluminescence and immunofluorescence reagents.
2. Norman's manufacture center is located in the Yuhua District and owns an over 2,000m2 GMP-approved clean workshop. The R&D base, which is over 2,000m2 , is located in state-level new Jiangbei district. Now there are over 100 R&D engineers, 40% of which hold a PhD or master's 
degree.

1536743397(1)_副本.jpg

1536743426(1)_副本.jpg


Agent Wanted: If you are interested in working with us, please feel free to contact. 


图片5.png    

Why Us:                                                                                                                

1. Manufacturer and Exporter for nearly 10 years with self R&D Research Center;

2. Professional After-Sale service with On-site support worldwide; 

3. CE/ISO13485/SGS/RoHS Certifications!


OEM and ODM are available !


Please feel free to give your inquiry in the form below. We will reply you in 24 hours.